Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study

Mostrar otras versiones (1)

For several years, adoptive immunotherapy (AIT) has been performed using autologous zoledronate-activated killer (ZAK) cells to develop a novel modality for cancer treatment. In the current study, data from 50 patients with incurable gastric cancer were analyzed. Patients were treated with AIT using...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Yoshiyuki, Katata, Yousuke, Sano, Fuminori, Tanioka, Hiroaki, Okawaki, Makoto, Yamamura, Masahiro, Nagasaka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468212/
https://www.ncbi.nlm.nih.gov/pubmed/32905239
http://dx.doi.org/10.3892/mco.2020.2125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468212/
https://www.ncbi.nlm.nih.gov/pubmed/32905239
http://dx.doi.org/10.3892/mco.2020.2125

Ejemplares similares